Pano News
Subscribe
Business

Bayer Roundup Settlement Approved

A court approved Bayer's $7.25 billion deal to settle Roundup cancer claims.

November 20, 2026 · Updated Nov 20, 8:39pm ET

34%

Left · 3

33%

Center · 3

33%

Right · 3

Pano counted 9 articles from 9 outlets: 34% left-leaning, 33% center and 33% right-leaning. Pano rates the coverage Balanced.

What happened

  • A Missouri judge on Friday approved a nationwide settlement under which Bayer will pay up to $7.25 billion to resolve Roundup cancer claims.
  • People suing Bayer alleged it should have warned that the weedkiller could cause non-Hodgkin lymphoma, while Bayer denies that Roundup causes cancer.
  • The settlement covers Roundup users already diagnosed with non-Hodgkin lymphoma and those diagnosed in future years.
  • The approval follows a Supreme Court ruling that barred state-court claims over missing cancer warnings when federal rules do not require them.
  • Bayer will pay over two decades, with participants potentially receiving averages ranging from $10,000 to $165,000 depending on their exposure, age at diagnosis and illness severity.

How the left told it

Left-leaning outlets ran reports from Reuters and the Associated Press rather than their own: The Guardian, Boston Globe and PBS NewsHour carried them.

How the right told it

Right-leaning outlets focused on the settlement’s financial and legal stakes. The Washington Examiner highlighted Bayer’s prospect of financial relief from mounting lawsuits and the Supreme Court’s limits on warning-label claims, while also noting elevated lymphoma rates among agricultural workers and the EPA’s position that glyphosate does not cause cancer when used as directed.

Topics in this story